These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28956186)

  • 1. Diabetic Nephropathy: a Tangled Web to Unweave.
    Magee C; Grieve DJ; Watson CJ; Brazil DP
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):579-592. PubMed ID: 28956186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy and multiorgan protection. Part II.
    Gluhovschi G; Gluhovschi C; Vlad A; Timar R; Bob F; Velciov S; Bozdog G; Petrica L
    Rom J Intern Med; 2011; 49(4):237-49. PubMed ID: 22568268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy: A twisted thread to unravel.
    Dagar N; Das P; Bisht P; Taraphdar AK; Velayutham R; Arumugam S
    Life Sci; 2021 Aug; 278():119635. PubMed ID: 34015285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
    Dugbartey GJ
    Pharmacol Rep; 2017 Apr; 69(2):331-339. PubMed ID: 28183033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms.
    Liu XJ; Hu XK; Yang H; Gui LM; Cai ZX; Qi MS; Dai CM
    Am J Chin Med; 2022; 50(7):1739-1779. PubMed ID: 36222120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
    Wang S; Qin S; Cai B; Zhan J; Chen Q
    Front Endocrinol (Lausanne); 2023; 14():932649. PubMed ID: 37522131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are new avenues for renal protection, in addition to RAAS inhibition?
    Hagiwara S; Kantharidis P; Cooper ME
    Curr Hypertens Rep; 2012 Apr; 14(2):100-10. PubMed ID: 22298106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current update in the management of diabetic nephropathy.
    Van Buren PN; Toto R
    Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.
    Lv M; Chen Z; Hu G; Li Q
    Drug Discov Today; 2015 Mar; 20(3):332-46. PubMed ID: 25448752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Management of Diabetic Nephropathy.
    Papademetriou V; Alataki S; Stavropoulos K; Papadopoulos C; Bakogiannis K; Tsioufis K
    Curr Vasc Pharmacol; 2020; 18(2):139-147. PubMed ID: 30961500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Phenotype and Fibrosis in Diabetic Nephropathy.
    Calle P; Hotter G
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrosis therapy and diabetic nephropathy.
    Karihaloo A
    Curr Diab Rep; 2012 Aug; 12(4):414-22. PubMed ID: 22644874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sex hormones in diabetic nephropathy.
    Liu J; Liu Z; Sun W; Luo L; An X; Yu D; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1135530. PubMed ID: 37143724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
    Zhang X; Zhang J; Ren Y; Sun R; Zhai X
    Front Endocrinol (Lausanne); 2024; 15():1368481. PubMed ID: 38455648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting inflammation in diabetic nephropathy: a tale of hope.
    Moreno JA; Gomez-Guerrero C; Mas S; Sanz AB; Lorenzo O; Ruiz-Ortega M; Opazo L; Mezzano S; Egido J
    Expert Opin Investig Drugs; 2018 Nov; 27(11):917-930. PubMed ID: 30334635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.
    Xue R; Gui D; Zheng L; Zhai R; Wang F; Wang N
    J Diabetes Res; 2017; 2017():1839809. PubMed ID: 28386567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
    Rayego-Mateos S; Morgado-Pascual JL; Opazo-Ríos L; Guerrero-Hue M; García-Caballero C; Vázquez-Carballo C; Mas S; Sanz AB; Herencia C; Mezzano S; Gómez-Guerrero C; Moreno JA; Egido J
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.